Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.96K Sell
253
-39,623
-99% -$1.3M ﹤0.01% 1087
2026
Q1
$1.49M Sell
39,876
-70,898
-64% -$2.92M 0.01% 632
2025
Q4
$5.18M Buy
+110,774
New +$4.79M 0.02% 453
2024
Q3
Sell
-204
Closed -$6.57K 1019
2024
Q2
$6.57K Hold
204
﹤0.01% 893
2024
Q1
$6.72K Buy
204
+38
+23% +$1.32K ﹤0.01% 926
2023
Q4
$5.76K Buy
+166
New +$5.73K ﹤0.01% 959
2021
Q4
Sell
-94,000
Closed -$4.47M 1279
2021
Q3
$4.47M Buy
+94,000
New +$4.67M 0.02% 575
2020
Q4
Sell
-133,800
Closed -$5.21M 1059
2020
Q3
$5.21M Sell
133,800
-203,500
-60% -$8.02M 0.04% 268
2020
Q2
$12.3M Buy
337,300
+165,600
+96% +$5.6M 0.1% 168
2020
Q1
$5.01M Buy
171,700
+113,293
+194% +$4.43M 0.04% 266
2019
Q4
$2.46M Sell
58,407
-14,093
-19% -$563K 0.02% 522
2019
Q3
$2.81M Buy
72,500
+39,331
+119% +$1.56M 0.02% 441
2019
Q2
$1.26M Buy
+33,169
New +$1.21M 0.01% 503

Other funds holding G

Natixis's G Position: Q2 2026 in Review

Natixis reduced its Genpact (G) stake by 99% in Q2 2026, selling an estimated $1.3M and leaving 253 shares worth $6.96K. The position accounts for ﹤0.01% of the portfolio, ranked #1087.

Natixis first reported a position in G in Q2 2019 and has held it in 13 quarters since. The position peaked at $12.3M in Q2 2020. 480 funds tracked by Wall St. Rank hold G as of Q2 2026.

  • Natixis held 253 shares of Genpact worth $6.96K as of Q2 2026.
  • Natixis sold 39,623 Genpact shares in Q2 2026, an estimated $1.3M.
  • Genpact made up ﹤0.01% of Natixis's portfolio in Q2 2026, its #1087 holding.
  • Natixis first reported a position in Genpact in Q2 2019 and has held it in 13 quarters since.
  • Natixis's Genpact position peaked at $12.3M in Q2 2020.
  • 480 funds tracked by Wall St. Rank held Genpact as of Q2 2026.

Based on Natixis's 13F filing for Q2 2026, filed 13 Aug 2026.